SERAFINI-LAMANNA TONY (Executive VP-Diagnostics) received a stock award from MERIDIAN BIOSCIENCE INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+7.95K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−43.34K
Price / share
—
Trade value
—
% of position
Net shares
−35.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2023 | A · Award | +7.95K | — | — | 22.4% | 35.39K | 43.34K |
| Common Stock Direct | 1/31/2023 | D · Disposition | −43.34K | — | — | New position | 43.34K | 0.00 |
| Total | −35.39K | $0.00 | ||||||
Stock Option (Right to Buy)
Common Stock
10K shares
Shares
−10K
Strike price
14.6
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
4K shares
Shares
−4K
Strike price
6.97
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
12.11K shares
Shares
−12.11K
Strike price
18.48
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
11.67K shares
Shares
−11.67K
Strike price
18.88
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 1/31/2023 | D · Disposition | −10K | 14.6 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock4K shares | 1/31/2023 | D · Disposition | −4K | 6.97 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock12.11K shares | 1/31/2023 | D · Disposition | −12.11K | 18.48 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock11.67K shares | 1/31/2023 | D · Disposition | −11.67K | 18.88 | — | 0.00 |